SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Human & Experimental Toxicology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Audebert, F.
Right arrow Articles by Bon, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Audebert, F.
Right arrow Articles by Bon, C.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Viper Bites in France: Clinical and Biological Evaluation; Kinetics of Envenomations

Françoise Audebert

Unité des Venins, Institut Pasteur, Paris

Marc Sorkine

Unité des Venins, Institut Pasteur, Paris, Service d'Anesthésie-Réanimation, Hôpital Henri Monclor, Creteil, France

Annie Robbe-Vincent

Unité des Venins, Institut Pasteur, Paris

Cassian Bon

Unité des Venins, Institut Pasteur, Paris

1 A second inquiry was conducted in France to collect more accurate epidemiological, clinical and biological data from patients hospitalized after a viper bite, as well as treatment that they received. Fifty-seven well documented cases were classified in four grades of increasing severity defined according to the clinical signs of envenomation.

2 Local and systemic signs of envenomation appeared during the first 3 h, but the severity of the envenomation was observed to increase during the 12-24 h following bites in 50% of moderate and severe cases. One fatal case was reported. Biological analysis revealed an hyperleukocytosis in patients with moderate and severe envenomations.

3 The average length of hospitalization was of 1.7 ± 1.3 days for patients without signs of envenomation (grade 0) or presenting a minimal envenomation (grade 1), and statistically longer, 6.2 ± 2.9 days, for patients presenting moderate (grade 2) or severe envenomation (grade 3).

4 Levels of venom antigens in serum samples regularly collected during hospitalization were determined by a sandwich ELISA test. The serum venom levels determined during the first 4 h following the bite correlated with the severity of the envenomation when the symptoms were determined at their worst, usually 12-24 h later. In fact, concentrations higher than 20 ng ml-1 predict a moderate or severe clinical evolution.

5 The pharmacokinetics of venom antigens was also investigated during human envenomations. Venom antigens could be detected in the serum of patients as soon as half an hour after the bite, then decreased exponentially during the following hours with an apparent half-life of 8 h, similar in grade 2 and grade 3 patients, indicating that the kinetics of venom antigens in blood is independent of the severity of the envenomation.

Human & Experimental Toxicology, Vol. 13, No. 10, 683-688 (1994)
DOI: 10.1177/096032719401301006


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement